SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Surgical Oncology (breast) Consultation — Richard Roundtree

PatientRichard Roundtree
Date of birth1975-07-09
IdentifiersMRN HR-ML015-SYN; SSN (made up) 000-15-8410
Document date2026-10-05
AuthorFarah Siddiqui, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Reason for Referral

Man of 51 with a new 1.5 cm firm, painless lump eccentric to the left nipple and a palpable left axillary node; breast cancer suspected. Diagnostic mammography, ultrasound, and core biopsy are booked for tomorrow. Please see him as soon as the results are back to plan surgery. [S]

Urgency: Urgent suspected-cancer pathway, within one week. [S]

Questions for the consultant:

History of Present Illness

Mr. Roundtree is seen at the request of Dr. Carrington. A few days before his first visit he found a painless lump under the left nipple in the shower and thought at first that it was the breast enlargement he had as a boy. Diagnostic mammography and ultrasound of both breasts and both axillae five days ago showed a 1.6 cm irregular retroareolar mass on the left and one abnormal left axillary node, with a normal right breast and axilla. Core biopsies of both show invasive ductal carcinoma, grade 3, ER 95 percent, PR 85 percent, HER2 1+, Ki-67 30 percent, with metastatic carcinoma in the node. He has no bone pain, cough, headache, or weight loss. He is fit, trains most days, and works as an actor. He says he did not know a man could get breast cancer, and he is worried about privacy at work. [S]

Historical basis. These claims are historical evidence, not findings from a modern examination.

6 later historical claims are omitted because they describe events after the index age. See the teaching note.

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Problems

ProblemClinical statusVerificationCodeProvenance
Invasive ductal carcinoma of the left male breast, central (retroareolar) portion, presenting as a 1.5 cm firm, painless lump eccentric to the left nipple with a palpable left axillary node; core biopsy: grade 3, ER positive, PR positive, HER2 negative, with metastatic carcinoma in the node; clinical stage IIA (cT1c cN1 M0); synthetic modern detail linked to his publicly disclosed breast canceractiveconfirmed C50.122S — Synthetic size, grade, receptor status, and stage; the left-sided lump, the operation, and the spread to lymph nodes are from his public account (D).
Estrogen receptor-positive status of the breast canceractiveconfirmed Z17.0S — Synthetic receptor result; his tumor biology was not made public.
New firm, painless lump of about 1.5 cm just off the left nipple, with a palpable left axillary node; suspected breast cancer, imaging and core biopsy bookedresolvedconfirmed N63.42S — Synthetic presenting concern at the index visit, superseded by the biopsy diagnosis; the left-sided lump is from his public account (D).

Physical Exam

Vital signs recorded on 2026-10-05; see the referring visit's Vital Signs section. [S]

SystemFinding
GeneralWell; anxious but composed
BreastsLeft: 1.5 cm firm, irregular mass eccentric to the nipple at 2 o'clock, not fixed to the chest wall or skin; no nipple retraction or discharge. Right: no mass and no glandular enlargement
Lymph nodesOne firm, mobile 1 cm left axillary node; no right axillary, supraclavicular, or cervical nodes
MusculoskeletalFull shoulder movement on both sides

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-10-05Hemoglobin [Mass/volume] in Blood14.8g/dL13.2-16.6 g/dLNormalS
2026-10-05Leukocytes [#/volume] in Blood by Automated count6.610*3/uL4-11 10*3/uLNormalS
2026-10-05Neutrophils [#/volume] in Blood by Automated count3.910*3/uL1.5-7.7 10*3/uLNormalS
2026-10-05Platelets [#/volume] in Blood by Automated count24610*3/uL150-400 10*3/uLNormalS
2026-10-05Sodium [Moles/volume] in Serum or Plasma139mmol/L135-145 mmol/LNormalS
2026-10-05Potassium [Moles/volume] in Serum or Plasma4.1mmol/L3.5-5.1 mmol/LNormalS
2026-10-05Creatinine [Mass/volume] in Serum or Plasma1.02mg/dL0.74-1.35 mg/dLNormalS
2026-10-05Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M89mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
2026-10-05Glucose [Mass/volume] in Serum or Plasma92mg/dL70-99 mg/dLNormalS
2026-10-05Calcium [Mass/volume] in Serum or Plasma9.5mg/dL8.6-10.3 mg/dLNormalS
2026-10-05Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma24U/L7-55 U/LNormalS
2026-10-05Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma22U/L8-48 U/LNormalS
2026-10-05Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma71U/L40-129 U/LNormalS
2026-10-05Bilirubin.total [Mass/volume] in Serum or Plasma0.7mg/dL0.1-1.2 mg/dLNormalS
2026-10-05Albumin [Mass/volume] in Serum or Plasma4.4g/dL3.5-5 g/dLNormalS
2026-10-05Patient Health Questionnaire 9 item (PHQ-9) total score [Reported]5{score}S

Assessment

Data reviewed: Diagnostic mammography and ultrasound of both breasts and both axillae; core biopsy pathology of the breast mass and the axillary node with ER, PR, HER2, and Ki-67; today's preoperative blood count and chemistry, all normal. [S]

Plan of Treatment